Effectiveness of Premedication on the Success Rate of Inferior Alveolar Nerve Block

NCT05097768 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Symptomatic Irreversible Pulpitis

Interventions

DRUG: Dexamethasone 0.5mg
DRUG: Ketorolac 10 Mg Oral Tablet
DRUG: Meloxicam 7.5 mg
DRUG: Ibuprofen 600 mg
DRUG: Placebo

Sponsor

Alfarabi Colleges